Current Opinion in Pharmacology
Publisher: Elsevier ·
ISSN 1471-4892 ·
15 articles
-
NOD1 and neurodegenerative diseases: Exploring the interplay between innate immune signaling and cognitive decline
Palak Kalra, Amarjot Kaur Grewal, Thakur Gurjeet Singh
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Beyond baseline risk: Node-matched pharmacology for infection-associated vascular events across myocardial infarction and acute mesenteric ischemia
Chen Juanlu
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Clinical application progress of neural stem cells
Lin Dai, Shu-xin Chen, Zhi-chun Yang
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Cyclosporine A revisited: Molecular mechanisms, non-immune physiological pathways, and the architecture of multi-organ toxicities
Rasha Mokhtar Abdelkareem, Walaa Obydah, Ahmed M. Abd-Eldayem
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Pharmacological control of inflammation via innate immune memory manipulation
Chirag Sharma, Sheenam Sharma, Sumeet Gupta
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Editorial: The future of inflammatory bowel disease is integration
Bram Verstockt, Virginia Solitano
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Pharmacological insights into fluvoxamine maleate: σ1 receptor agonism, multimodal mechanisms, and therapeutic repositioning
Chirag Sharma, Sheenam Sharma, Rishabh Chaudhary, Satish Kumar, Seema Bansal, Anroop Nair, Sumeet Gupta
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Mitochondrial metabolic reprogramming and neutrophil extracellular traps (NETs) dynamic balance: Dual-axis regulatory mechanisms and therapeutic prospects for acute lung injury repair
Yi Yuan, Yuting Lai, Ling Ruan, Zhiru Qiu, Li Liu, Jing Jia
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Nanomedicines and drug delivery systems for modulating immune training in cancer and infectious diseases
P.S. Shishira, Swapnil Gore, Swati Biswas, Balaram Ghosh
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Polycystic ovary syndrome: An insight into pathophysiology, current management, and emerging therapeutic approaches
Garima Sahu, Amit Kumar Goyal
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Piezo1 and Piezo2 in neurological disorders: From mechanotransduction to therapeutic potential
Lu Zhao, Chao Wang, Yudan Zhu, Qian Xiao, Jie Tao
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Advancing analgesic development for peripheral neuropathic pain: Multi-targeting sodium channels
Yuchen Shen, Yi Wang, Can Liu, Jialin Feng, Juan Deng, Liting Sun
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Therapeutic targeting of trained immunity in cancer
Bhumika Deb, Khushal Khambhati, Rakesh Rawal, Ankit Rai, Vijai Singh
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
miR-124 upregulation as a new therapeutic strategy: The evolving role of obefazimod in ulcerative colitis
Viviana Parra-Izquierdo, Virginia Solitano, Bram Verstockt
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01
-
Trained immunity in hyperuricemia and gout: Targeting epigenetic marks to reduce cardiovascular risk
Nils Asmann, Brenda Kischkel, Leo A.B. Joosten
Current Opinion in Pharmacology
· Drug Discovery
· 2026-12-01